Prescriber Scope of Practice for General Psychiatry in North Carolina

The short answer: Yes, but with important caveats.

As of early 2026, psychiatrists, PMHNPs, and other prescribers can legally prescribe controlled substances via telehealth to new patients without an initial in-person visit—thanks to federal emergency flexibilities extended through December 31, 2026. But this is temporary. The DEA is finalizing permanent rules that will reshape how telepsychiatry works, and state laws add another layer of complexity.

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can prescribe ADHD meds, benzodiazepines, or buprenorphine through a telehealth platform—or if you’re trying to expand your practice across state lines—this guide breaks down exactly what you need to know right now.

Where We Stand: Federal DEA Rules in 2026

Current Reality (Through End of 2026):

The DEA and HHS announced a fourth extension of COVID-era telehealth prescribing flexibilities on January 2, 2026. This means you can continue prescribing Schedule II–V controlled substances via telemedicine without requiring an in-person exam first—as long as you conduct a proper evaluation via real-time, two-way audio-video communication and it’s for a legitimate medical purpose.

In practice: A new patient with ADHD can schedule a video appointment with you, you can evaluate them thoroughly, and you can prescribe Adderall or Vyvanse (Schedule II stimulants) electronically to their pharmacy. No in-person visit required under federal law, at least through December 2026.

The critical caveat: These are temporary rules. Once the DEA finalizes its permanent telehealth regulations (expected sometime in 2026), the landscape will change significantly.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What’s Coming: DEA’s Proposed Permanent Rules

In January 2025, the DEA announced three proposed rules that will replace the temporary flexibilities:

1. Special Telemedicine Registration for Schedule II Prescribing

The DEA is creating a new ‘Special Telemedicine Prescriber Registration’ that would allow qualified providers to prescribe controlled substances to new patients via telehealth without any in-person exam.

Here’s what matters for psychiatrists:

• You’re explicitly included. Board-certified psychiatrists will be eligible for this special registration to prescribe Schedule II substances (like stimulants for ADHD) via telehealth.
• No in-person requirement. With this registration, you could manage ADHD, anxiety, and other conditions entirely via video visits for new patients who’ve never been seen in person.
• Platform accountability. Online telehealth platforms will also need to register with the DEA for the first time, and there will be a national PDMP to track prescriptions across states.

For Schedule III–V substances (many anxiety meds, some sleep aids), any qualified prescriber could obtain the special registration. But for Schedule II, the DEA is limiting initial eligibility to psychiatrists, hospice/palliative care doctors, long-term care facility physicians, and select pediatricians.

2. Buprenorphine Treatment Expansion

If you treat opioid use disorder, this matters: The DEA is proposing to allow up to 6 months of buprenorphine treatment via telehealth (including audio-only for initial consultations) before requiring an in-person visit. After 180 days, you’d need to see the patient in person or refer them to someone who can.

This is more permissive than current law and acknowledges how telehealth has transformed addiction treatment access.

3. If a Patient Has Ever Been Seen In Person, You’re Clear

One bright spot in the upcoming rules: If your patient was ever examined in person by any qualified provider (not necessarily you), there’s no federal restriction on prescribing controlled substances via telehealth for ongoing care. The in-person requirement is already satisfied.

So if a patient saw their primary care doctor last year and now wants to start telepsychiatry with you for ADHD management, you’re good to go under federal law—both now and under the proposed rules.

The Economics Reality: Why Platforms Like Klarity Make Sense

Let’s talk about what it actually costs to build a telehealth psychiatry practice on your own.

The DIY Marketing Math:

• SEO takes 6–12 months of consistent investment (content, technical optimization, link building) before you see meaningful patient flow. You’re looking at $2,000–5,000/month for an agency or consultant who knows healthcare SEO, plus your time.
• Google Ads for mental health keywords run $15–40+ per click. Most clicks don’t book. When you factor in ad spend, testing, optimization, and no-shows from cold leads, your cost per booked patient is typically $200–400+.
• Directory listings (Psychology Today, Zocdoc) charge monthly fees ($30–150/month) AND you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35–100+), and that doesn’t include the subscription cost.
• Reality check: When you add up agency fees, ad spend, staff time to handle and qualify leads, no-show rates, failed campaigns, and months of SEO investment, acquiring a qualified psychiatric patient through DIY marketing typically costs $200–500+ all in.

The Platform Alternative:

Klarity Health uses a pay-per-appointment model. You pay a standard listing fee per new patient lead—but only when a qualified patient actually books with you. No upfront marketing spend. No monthly subscriptions. No wasted ad spend on clicks that don’t convert.

Key advantages:

• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients
• Guaranteed ROI vs. gambling $3,000–5,000/month on marketing with uncertain results

For most providers—especially those starting out or scaling quickly—a platform that handles patient acquisition removes all the risk and overhead of building your own marketing machine.

State-Specific Rules: Where Things Get Complicated

Federal law sets the floor, but states can (and do) impose stricter requirements. Here’s what you need to know for our priority states:

California: Telehealth-Friendly, But Check CURES

California doesn’t impose extra telehealth prescribing restrictions beyond federal law. You can establish a valid patient relationship via video and prescribe controlled substances accordingly.

Key requirements:

• CURES PDMP: You must check California’s prescription monitoring database before prescribing Schedule II–IV controlled substances to a new patient, and every 4 months for ongoing treatment.
• 100% e-prescribing mandate (since January 2022)—paper scripts aren’t allowed except in rare cases.
• PMHNP scope: California is transitioning to full practice authority for experienced psychiatric NPs. By 2026, PMHNPs with 3+ years of supervised experience can practice completely independently.

Texas: Physician-Friendly, NP-Limited

Texas explicitly permits telehealth psychiatry via video without requiring an in-person exam for mental health conditions.

Critical limitations:

• NPs cannot prescribe Schedule II outside of hospital or hospice settings. That means a Texas PMHNP cannot prescribe Adderall, Ritalin, or other stimulants for outpatient ADHD care. You need a psychiatrist (MD/DO) for those prescriptions.
• Texas PMP mandatory before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol.
• Chronic pain prescribing via telehealth requires at least one in-person visit (but this rarely affects psychiatry).

If you’re running a telepsychiatry service in Texas, plan on pairing PMHNPs with psychiatrists so MDs can handle Schedule II prescriptions.

Florida: Psychiatric Exception Saves the Day

Florida has strict telehealth controlled substance rules—with one major carve-out for psychiatry.

The rules:

• Schedule II substances cannot be prescribed via telehealth UNLESS it’s for: (1) psychiatric disorder treatment, (2) inpatient hospital care, (3) hospice, or (4) nursing home residents.
• Good news: Since ADHD is a psychiatric disorder, you can prescribe Adderall and other Schedule II stimulants via telehealth in Florida.
• Out-of-state providers can register as Florida telehealth providers without a full Florida license—but you’re still bound by the same prescribing rules.
• E-FORCSE PDMP: Must check before prescribing any controlled substance to patients 16+.
• PMHNP limitation: Psychiatric NPs in Florida require a collaborative agreement with a physician. They can’t practice independently.

New York: I-STOP and E-Prescribing

New York is generally telehealth-friendly and doesn’t impose extra controlled substance prescribing restrictions for telehealth.

Key compliance points:

• I-STOP/PMP mandatory: You must check New York’s prescription monitoring program before prescribing every Schedule II, III, or IV controlled substance. This is one of the strictest PDMP mandates in the country.
• 100% e-prescribing for all prescriptions (not just controlled substances) since 2016.
• PMHNP independence: Experienced psychiatric NPs (3,600+ hours) can practice completely independently in New York—no physician collaboration required.

Pennsylvania: Standard of Care, No Special Restrictions

Pennsylvania doesn’t have a comprehensive telehealth statute yet, but the medical board allows telemedicine under general practice standards.

What you need to know:

• No blanket telehealth prescribing ban for controlled substances—follow federal law and standard of care.
• PA PDMP mandatory before prescribing opioids or benzodiazepines (check every time for initial prescriptions).
• E-prescribing required for Schedule II–V since October 2019.
• PMHNP scope: Psychiatric NPs need a collaborative agreement with at least one physician (effectively two for prescriptive authority). They can prescribe Schedule II for up to 30 days, Schedule III–IV for up to 90 days with physician collaboration.

Illinois: Full Practice Available, With Quirks

Illinois offers full practice authority for experienced PMHNPs—but with some strings attached.

Key points:

• Full Practice Authority (FPA) available for NPs with 4,000 clinical hours and additional training. With FPA, you can practice independently.
• Benzodiazepine/Schedule II limitation: Even with FPA, Illinois NPs must enter a ‘consultation relationship’ with a physician to prescribe benzodiazepines or Schedule II opioids, limited to 30-day supplies. (The law’s wording suggests this may apply to stimulants too—check with your attorney.)
• IL PMP mandatory before prescribing opioids each time; recommended for other controlled substances.
• E-prescribing required for all controlled substances since January 2023.

Multi-State Practice: Licensing and DEA Registration

Here’s what many providers miss: Telehealth legally occurs where the patient is located, not where you are.

If you’re treating a patient in California while sitting in your New York office, you need:

• A California medical license
• A DEA registration in California (with a California address)
• Registration with California’s CURES PDMP
• Compliance with all California prescribing laws

Interstate Medical Licensure Compact (IMLC) membership can help. California, Texas, Pennsylvania, and Illinois are members, which streamlines getting licensed in multiple states. But you still need separate licenses—the compact just makes the process faster and cheaper.

New York and Florida are not in the IMLC as of 2026, so licensing there takes longer.

The practical reality: Most successful telehealth psychiatrists either (1) maintain licenses in 3–5 high-population states, or (2) join a platform that handles multi-state compliance and patient routing.

Compliance Essentials: What You Must Do

Regardless of state, here are non-negotiables for telehealth controlled substance prescribing:

1. Conduct a Proper Evaluation

‘Proper’ means:

• Comprehensive psychiatric history
• Mental status examination
• Review of prior treatments and medications
• Assessment of substance use and diversion risk
• Documentation that supports your diagnosis and treatment plan

A 15-minute video call and a prescription won’t cut it. State medical boards are disciplining providers who prescribe after inadequate evaluations—especially for controlled substances.

2. Use Real-Time, Two-Way Video

Audio-only telephone calls generally don’t satisfy federal telemedicine requirements for controlled substances (except for buprenorphine in the proposed rules). Use HIPAA-compliant video platforms.

3. Check Your State’s PDMP Every Time

Most states mandate prescription monitoring program checks before prescribing controlled substances. Many require checks at specific intervals (e.g., California every 4 months, New York every time).

Interstate PDMP data exchange means you can often see prescriptions from neighboring states—use it.

4. E-Prescribe Everything

Federal law requires e-prescribing for Medicare Part D controlled substances. Most states mandate it for all controlled prescriptions. Your e-prescribing system must be DEA-compliant (two-factor authentication, audit trails).

5. Complete Your DEA Training Requirement

As of 2023, all DEA registrants must complete an 8-hour training on substance use disorder and appropriate prescribing before their next DEA renewal. Board-certified addiction psychiatrists are exempt, but everyone else needs it.

6. Document Everything

In telehealth, your documentation is your defense. Include:

• How you established the patient relationship (video visit on X date)
• Clinical justification for controlled substance prescription
• PDMP check results
• Discussion of risks, alternatives, and monitoring plan
• Any state-specific requirements (like Florida’s psychiatric indication notation)

FAQ: What Providers Actually Ask

Can I prescribe Adderall to a new patient I’ve only seen via video?

Under current federal rules (through December 2026): Yes, as long as you conduct a thorough evaluation via two-way video and it’s for a legitimate medical purpose. State law may add requirements—check your state’s rules above.

What happens when the DEA temporary extension expires?

You’ll likely need to obtain a ‘Special Telemedicine Registration’ to continue prescribing Schedule II substances to new patients via telehealth without in-person exams. The DEA is expected to finalize this process in 2026.

Can I treat patients in multiple states via telehealth?

Yes, but you need a medical license and DEA registration in every state where your patients are located. Platforms like Klarity Health can help route patients to appropriately licensed providers.

Do PMHNPs have the same prescribing authority as psychiatrists?

It depends entirely on state law. In New York (with experience) and California (soon): yes. In Texas and Florida: no—they need physician supervision and have significant limitations on Schedule II prescribing.

Can I do audio-only telehealth for controlled substance prescribing?

Generally no, except for buprenorphine under the proposed DEA rules. Standard of care and federal requirements strongly favor video visits for initial evaluations and controlled substance prescribing.

What’s the biggest compliance mistake providers make?

Inadequate initial evaluations. Prescribing stimulants after a brief video call without comprehensive psychiatric assessment is a red flag for medical boards and DEA.

How much does it cost to acquire patients through telehealth?

DIY marketing typically costs $200–500+ per qualified patient when you factor in all costs. Platforms that charge per appointment only (like Klarity) eliminate upfront risk and wasted spend on clicks that don’t convert.

The Bottom Line for Psychiatrists and PMHNPs

Yes, you can prescribe controlled substances via telehealth in 2026—and for the foreseeable future, with some regulatory evolution ahead.

Here’s what matters:

• Federal flexibility continues through December 2026 for prescribing to new patients without in-person exams
• Permanent DEA rules will likely require special registration but will preserve telehealth access for qualified psychiatrists
• State laws vary significantly—Texas and Florida have important limitations, especially for PMHNPs
• Compliance requires thorough evaluations, PDMP checks, e-prescribing, and detailed documentation
• Building your own patient acquisition engine costs $200–500+ per patient; platforms that charge per appointment eliminate that risk entirely

If you’re looking to expand your psychiatric practice via telehealth—or you’re considering whether to invest in building your own marketing infrastructure vs. joining an established platform—the economics are clear. Platforms like Klarity Health that handle patient acquisition, credentialing, and compliance infrastructure let you focus on what you do best: treating patients.

Ready to expand your telepsychiatry practice without the marketing headaches? Klarity Health connects psychiatrists and PMHNPs with qualified patients who need your expertise. No upfront costs, no wasted marketing spend—just patients matched to your specialty and schedule. Explore joining Klarity’s provider network.

Citations

1. HHS Press Release: ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ (January 2, 2026) – https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. DEA Press Release: ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Medications While Establishing Important Patient Protections’ (January 16, 2025) – https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. Florida Statutes §456.47: Use of Telehealth to Provide Services (2025 edition) – http://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

4. Akerman LLP: ‘Harmonizing Federal and Florida Laws on Prescribing Controlled Substances Through Telehealth’ (March 2023) – https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html

5. Texas Medical Board: Prescriptive Authority FAQs (Updated 2024) – https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=WASHINGTON%E2%80%94JANUARY%202%2C%202026%E2%80%94The%20U,while%20permanent%20rules%20are%20finalized
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=Expansion%20of%20Buprenorphine%20Treatment%20via,Telemedicine%20Encounter
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=For%20the%20first%20time%20online,being%20of%20patients
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=In%20developing%20these%20rules%2C%20DEA,person%20by%20the%20medical%20provider
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=telehealth%20to%20prescribe%20schedules%20III,one%20of%20the%20following%20categories
• https://www.jdsupra.com/legalnews/states-and-feds-signal-big-changes-to-9301791/#:~:text=of%20Ohio%E2%80%99s%20new%20telehealth%20prescribing,substance%20use%20disorder%20treatment%2C%20is
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=No%20special%20registration%20is%20required,the%20State%20to%20do%20so
• https://www.tebra.com/theintake/checklists-and-guides/legal-and-compliance/nurse-practitioner-laws-by-state#:~:text=,start%20their%20own%20medical%20practices